JP2007501627A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501627A5
JP2007501627A5 JP2006523302A JP2006523302A JP2007501627A5 JP 2007501627 A5 JP2007501627 A5 JP 2007501627A5 JP 2006523302 A JP2006523302 A JP 2006523302A JP 2006523302 A JP2006523302 A JP 2006523302A JP 2007501627 A5 JP2007501627 A5 JP 2007501627A5
Authority
JP
Japan
Prior art keywords
subject
allele
genotype
osteoporosis
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006523302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501627A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/025858 external-priority patent/WO2005013809A2/en
Publication of JP2007501627A publication Critical patent/JP2007501627A/ja
Publication of JP2007501627A5 publication Critical patent/JP2007501627A5/ja
Withdrawn legal-status Critical Current

Links

JP2006523302A 2003-08-08 2004-08-09 骨粗鬆症のための診断法および治療法 Withdrawn JP2007501627A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49386103P 2003-08-08 2003-08-08
PCT/US2004/025858 WO2005013809A2 (en) 2003-08-08 2004-08-09 Diagnostic and therapeutics for osteoporosis

Publications (2)

Publication Number Publication Date
JP2007501627A JP2007501627A (ja) 2007-02-01
JP2007501627A5 true JP2007501627A5 (https=) 2007-03-29

Family

ID=34135292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523302A Withdrawn JP2007501627A (ja) 2003-08-08 2004-08-09 骨粗鬆症のための診断法および治療法

Country Status (10)

Country Link
US (1) US7723028B2 (https=)
EP (1) EP1680513B1 (https=)
JP (1) JP2007501627A (https=)
KR (1) KR20060061350A (https=)
CN (1) CN1863928A (https=)
AT (1) ATE490339T1 (https=)
AU (1) AU2004263184B2 (https=)
CA (1) CA2534365A1 (https=)
DE (1) DE602004030367D1 (https=)
WO (1) WO2005013809A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2534365A1 (en) 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
US8105775B2 (en) * 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
EP2089538B1 (en) * 2006-11-15 2013-08-21 Interleukin Genetics, Inc. The il-1 gene cluster and insulin resistance: associated polymorphisms, haplotypes and methods of using same
KR100909709B1 (ko) * 2007-03-30 2009-07-30 대한민국 골밀도 및 골절 위험과 itga1 유전자 다형성과의연관성
US20100112570A1 (en) * 2008-10-22 2010-05-06 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
WO2010083294A2 (en) * 2009-01-16 2010-07-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
DK0652975T3 (da) 1992-07-31 2005-02-14 Garvan Inst Med Res Vurdering af allelvariation med hensyn til trans-virkende faktorer
JP3472587B2 (ja) 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
CA2152667C (en) 1992-12-28 2003-02-11 David J. Baylink Bone resorption assay
DE69433811T2 (de) 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5942390A (en) 1996-01-12 1999-08-24 Cedars-Sinai Medical Center Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9621129D0 (en) * 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
MXPA02002251A (es) 1999-08-30 2003-08-20 Interleukin Genetics Inc Diagnosticos y terapeuticos para osteoporosis.
JP2002345500A (ja) * 2000-12-22 2002-12-03 Pfizer Prod Inc 炎症性障害を発展させる増加したリスクを検出するための方法および試薬
CA2450809A1 (en) * 2001-06-15 2002-12-27 Interleukin Genetics, Inc. Methods for detecting and treating the early onset of aging-related conditions
CA2534365A1 (en) 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis

Similar Documents

Publication Publication Date Title
US12180548B2 (en) Detection of target nucleic acids using hybridization
JP2003500071A5 (https=)
CN117051132B (zh) 绵羊snp分子标记及其在绵羊抗布鲁氏菌病性状检测中的应用
JP2002533096A5 (https=)
RU2018122965A (ru) Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания
JP2017526347A (ja) ハイブリッド形成を使用した標的核酸の検出
EP2847593A1 (en) Methods for predicting and detecting cancer risk
JP2007501627A5 (https=)
JP2011520433A5 (https=)
JP2013544536A5 (https=)
US20180216190A1 (en) Single Nucleotide Polymorphism in HLA-B*15:02 and Use Thereof
CN117051131A (zh) 与绵羊抗布鲁氏菌病性状相关的snp分子标记及其检测引物和应用
CN117070643B (zh) 与绵羊布鲁氏菌病抗性相关的snp分子标记及其应用
CN117051133B (zh) 用于检测绵羊布鲁氏菌病抗性的snp分子标记及其检测引物和应用
CN117051135B (zh) 一种绵羊布鲁氏菌病抗性snp分子标记及其应用
JP2006521812A5 (https=)
JP4228041B2 (ja) 塩基多型の検出方法
CN110205363A (zh) 载脂蛋白e基因kasp分型检测试剂盒及其方法
Shi et al. Application of kinetic polymerase chain reaction and molecular beacon assays to pooled analyses and high‐throughput genotyping for candidate genes
US20160060696A1 (en) Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w)
US20100144776A1 (en) Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1)
KR101100437B1 (ko) 단일염기 다형을 포함하는 대장암과 관련된 폴리뉴클레오티드, 그를 포함하는 마이크로어레이 및 진단 키트 및 그를 이용한 대장암의 진단방법
KR20110034297A (ko) 내인성 아토피 피부염 진단용 마커 및 그의 용도
US20140154209A1 (en) Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance
Tirado et al. Rapid detection of the 46C→ T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes